Seroepidemiological Reconstruction of Long-term Chikungunya Virus Circulation in Burkina Faso and Gabon

Autor: Lim, Jacqueline Kyungah, Ridde, Valery, Agnandji, Selidji Todagbe, Lell, Bertrand, Yaro, Seydou, Yang, Jae Seung, Hoinard, Damien, Weaver, Scott C, Vanhomwegen, Jessica, Salje, Henrik, Yoon, In-Kyu
Přispěvatelé: Salje, Henrik [0000-0003-3626-4254], Apollo - University of Cambridge Repository, Apollo-University Of Cambridge Repository, International Vaccine Institute (IVI), School of Public Health [Montréal, Canada], Université de Montréal (UdeM), Centre de Recherches Médicales de Lambaréné, University of Tübingen, Medizinische Universität Wien = Medical University of Vienna, Centre Muraz [Bobo-Dioulasso, Burkina Faso], Institut Pasteur [Paris] (IP), University of Texas Medical Branch at Galveston, University of Cambridge [UK] (CAM), Coalition for Epidemic Preparedness Innovations [Washington, DC, États-Unis] (CEPI), H. S. was supported by the European Research Council (grant number 804744). I.-K. Y. and J. K. L. were supported by the Bill & Melinda Gates Foundation (grant number 1053432). S. C. W. was supported by the National Institutes of Health (grant number R24 AI120942).Potential conflicts of interest. H. S. reports being a paid consultant to Gavi, the Vaccine Alliance, for work understanding the potential of chikungunya vaccines. All other authors report no potential conflicts. Funding to pay the Open Access publication charges for this article was provided by the University of Cambridge., European Project: 804744,H2020-EU.1.1.,ARBODYNAMIC(2019)
Rok vydání: 2022
Předmět:
Zdroj: Journal of Infectious Diseases
Journal of Infectious Diseases, 2022, pp.jiac246. ⟨10.1093/infdis/jiac246⟩
ISSN: 1537-6613
0022-1899
DOI: 10.1093/infdis/jiac246
Popis: Chikungunya virus (CHIKV) is a major public health concern worldwide. However, infection levels are rarely known, especially in Africa. We recruited individuals from Ouagadougou, Burkina Faso and Lambaréné, Gabon (age range, 1–55 years), tested their blood for CHIKV antibodies, and used serocatalytic models to reconstruct epidemiological histories. In Ouagadougou, 291 of 999 (29.1%) individuals were seropositive, ranging from 2% among those aged
Databáze: OpenAIRE